NIAID Blue Ribbon Panel Meeting on Adjuvant Discovery and Development, 66766 [2010-27317]
Download as PDF
<![CDATA[
66766
Federal Register / Vol. 75, No. 209 / Friday, October 29, 2010 / Notices
BILLING CODE 4150–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
NIAID Blue Ribbon Panel Meeting on
Adjuvant Discovery and Development
Notice is hereby given that the
National Institute of Allergy and
Infectious Diseases (NIAID), a
component of the National Institutes of
Health (NIH) of the Department of
Health and Human Services (DHHS),
will convene a Blue Ribbon Panel to
provide expertise in developing a
strategic plan and research agenda for
the discovery, development and clinical
evaluation of adjuvants for use with
preventive vaccines. NIAID has
developed a draft Strategic Plan and
Research Agenda for Adjuvant
Discovery and Development, which
summarizes the current status of
research in the field of preventive
vaccine adjuvants, identifies gaps in
knowledge and capabilities, and defines
NIAID’s goals for the continued
discovery, development and application
of adjuvants for human vaccines that
protect against infectious disease. The
Panel will review the draft Strategic
Plan and Research Agenda and
recommend ways the NIAID can
enhance its adjuvant research programs.
DATES: November 17–18, 2010.
ADDRESSES: The meeting location is:
Rockville—Hilton Hotel (Roosevelt
Room), 1750 Rockville Pike, Rockville,
MD 20850.
FOR FURTHER INFORMATION CONTACT: Ms.
Grace Tollini-Farrell, 301–496–7551.
Dated: October 21, 2010.
Daniel Rotrosen,
Director, Division of Allergy, Immunology and
Transplantation, NIAID, National Institutes
of Health.
BILLING CODE 4140–01–P
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
National Institute of
Environmental Health Sciences
(NIEHS), National Institutes of Health,
HHS.
ACTION: Extension of public comment
period.
Jkt 223001
BILLING CODE 4140–01–P
[Document Identifier: CMS–10319]
National Toxicology Program (NTP);
Office of Liaison, Policy and Review;
Meeting of the NTP Board of Scientific
Counselors: Amended Notice
15:23 Oct 28, 2010
[FR Doc. 2010–27424 Filed 10–28–10; 8:45 am]
Centers for Medicare & Medicaid
Services
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Mar<15>2010
Dated: October 21, 2010.
John R. Bucher,
Associate Director, National Toxicology
Program.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–27317 Filed 10–28–10; 8:45 am]
AGENCY:
The NTP announces an
amended date for submission of written
public comments for the November 30–
December 1, 2010 meeting of the NTP
Board of Scientific Counselors (BSC).
Information regarding the BSC meeting
was published on October 19, 2010, in
the Federal Register (75 FR 201) and is
available on the BSC meeting page
(https://ntp.niehs.nih.gov/go/165). The
guidelines and deadlines published in
this Federal Register notice still apply,
except that the deadline for submission
of written comments is extended to
November 16, 2010.
DATES: The BSC meeting will be held on
November 30–December 1, 2010. The
deadline for submission of written
comments and for pre-registration to
attend the meeting, including registering
to present oral comments, is November
16, 2010.
ADDRESSES: The BSC meeting will be
held in the Rodbell Auditorium, Rall
Building at the NIEHS, 111 T.W.
Alexander Drive, Research Triangle
Park, NC 27709. Public comments on all
agenda topics and any other
correspondence should be submitted to
Dr. Lori White, Designated Federal
Officer for the BSC, NTP Office of
Liaison, Policy and Review, NIEHS, P.O.
Box 12233, K2–03, Research Triangle
Park, NC 27709; telephone: 919–541–
9834; fax: 919–541–0295;
whiteld@niehs.nih.gov. Courier address:
NIEHS, 530 Davis Drive, Room K2136,
Morrisville, NC 27560.
FOR FURTHER INFORMATION CONTACT: Dr.
Lori D. White (telephone: 919–541–9834
or whiteld@niehs.nih.gov).
SUMMARY:
[FR Doc. 2010–27412 Filed 10–28–10; 8:45 am]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
AGENCY:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Pre-Existing
Condition Insurance Plan Program
Solicitation and Contractor’s Proposal
Package; Use: The Department of Health
and Human Services (HHS) is
requesting a renewal of this package by
the Office of Management and Budget
(OMB); specifically, HHS is now seeking
a three-year approval for this collection.
On March 23, 2010, the President signed
into law H.R. 3590, the Patient
Protection and Affordable Care Act
(Affordable Care Act), Public Law 111–
148. Section 1101 of the law establishes
a ‘‘temporary high risk health insurance
pool program’’ (which has been named
the Pre-Existing Condition Insurance
Plan, or PCIP) to provide health
insurance coverage to currently
uninsured individuals with pre-existing
conditions. The law authorizes HHS to
carry out the program directly or
through contracts with States or private,
non-profit entities.
This package renewal is requested as
a result of a possible transition in
administration of the program from a
Federally-run to a State administered
program. A State who originally decided
to have HHS administer the program in
their State may in the future notify HHS
of their desire to administer the PreExisting Condition Plan (PCIP) program.
PCIP is also referred to as the temporary
qualified high risk insurance pool
program, as it is called in the Affordable
Care Act, but we have adopted the term
PCIP to better describe the program and
avoid confusion with the existing State
high risk pool programs. Form Number:
CMS–10319 (OMB#: 0938–1085);
Frequency: Occasionally; Affected
Public: State governments; Number of
Respondents: 2; Total Annual
Responses: 2; Total Annual Hours:
2,992. (For policy questions regarding
this collection contact Laura Dash at
301–492–4296. For all other issues call
410–786–1326.)
E:\FR\FM\29OCN1.SGM
29OCN1
]]>Agencies
[Federal Register Volume 75, Number 209 (Friday, October 29, 2010)]
[Notices]
[Page 66766]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-27317]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
NIAID Blue Ribbon Panel Meeting on Adjuvant Discovery and
Development
Notice is hereby given that the National Institute of Allergy and
Infectious Diseases (NIAID), a component of the National Institutes of
Health (NIH) of the Department of Health and Human Services (DHHS),
will convene a Blue Ribbon Panel to provide expertise in developing a
strategic plan and research agenda for the discovery, development and
clinical evaluation of adjuvants for use with preventive vaccines.
NIAID has developed a draft Strategic Plan and Research Agenda for
Adjuvant Discovery and Development, which summarizes the current status
of research in the field of preventive vaccine adjuvants, identifies
gaps in knowledge and capabilities, and defines NIAID's goals for the
continued discovery, development and application of adjuvants for human
vaccines that protect against infectious disease. The Panel will review
the draft Strategic Plan and Research Agenda and recommend ways the
NIAID can enhance its adjuvant research programs.
DATES: November 17-18, 2010.
ADDRESSES: The meeting location is: Rockville--Hilton Hotel (Roosevelt
Room), 1750 Rockville Pike, Rockville, MD 20850.
FOR FURTHER INFORMATION CONTACT: Ms. Grace Tollini-Farrell, 301-496-
7551.
Dated: October 21, 2010.
Daniel Rotrosen,
Director, Division of Allergy, Immunology and Transplantation, NIAID,
National Institutes of Health.
[FR Doc. 2010-27317 Filed 10-28-10; 8:45 am]
BILLING CODE 4140-01-P
